190 related articles for article (PubMed ID: 34358691)
1. Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review.
Shi Y; Wang C
Clin Immunol; 2021 Sep; 230():108819. PubMed ID: 34358691
[TBL] [Abstract][Full Text] [Related]
2. [Acquired C1 esterase inhibitor deficiency via bradykinin-mediated angioedema: Four cases].
Jacquin-Porretaz C; Castelain F; Daguindau E; Seilles E; Nardin C; Aubin F; Pelletier F
Ann Dermatol Venereol; 2018 Oct; 145(10):598-602. PubMed ID: 29673745
[TBL] [Abstract][Full Text] [Related]
3. Acquired C1 Inhibitor Deficiency.
Otani IM; Banerji A
Immunol Allergy Clin North Am; 2017 Aug; 37(3):497-511. PubMed ID: 28687105
[TBL] [Abstract][Full Text] [Related]
4. The acquired deficiency of C1-inhibitor: lymphoproliferation and angioedema.
Cicardi M; Zanichelli A
Curr Mol Med; 2010 Jun; 10(4):354-60. PubMed ID: 20455857
[TBL] [Abstract][Full Text] [Related]
5. The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity.
Wu MA; Castelli R
Clin Chem Lab Med; 2016 Feb; 54(2):207-14. PubMed ID: 26068904
[TBL] [Abstract][Full Text] [Related]
6. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation.
Cugno M; Castelli R; Cicardi M
Autoimmun Rev; 2008 Dec; 8(2):156-9. PubMed ID: 19014872
[TBL] [Abstract][Full Text] [Related]
7. Acquired angioedema in B cell lymphoproliferative disease: A retrospective case series.
Wonnaparhown A; Stefanovic A; Lugar P; Hostetler HP
Clin Exp Immunol; 2021 Dec; 206(3):378-383. PubMed ID: 34586637
[TBL] [Abstract][Full Text] [Related]
8. Angioedema due to acquired C1-inhibitor deficiency: spectrum and treatment with C1-inhibitor concentrate.
Bork K; Staubach-Renz P; Hardt J
Orphanet J Rare Dis; 2019 Mar; 14(1):65. PubMed ID: 30866985
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency.
Zanichelli A; Azin GM; Wu MA; Suffritti C; Maggioni L; Caccia S; Perego F; Vacchini R; Cicardi M
J Allergy Clin Immunol Pract; 2017; 5(5):1307-1313. PubMed ID: 28284781
[TBL] [Abstract][Full Text] [Related]
10. Acquired Angioedema due to C1-Inhibitor Deficiency: A Challenging Condition.
Valle SOR; Alonso MLO; Dortas Junior SD; Goudouris ES; de Carvalho ALRB; Capelo AV; Mansour E; Bernardes AF; Leite LFB; Giavina-Bianchi P; Aun MV; Ferriani MPL; Arruda LK; Grumach AS
Int Arch Allergy Immunol; 2022; 183(5):572-577. PubMed ID: 35325890
[TBL] [Abstract][Full Text] [Related]
11. Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH)-A Bicenter Retrospective Study on Diagnosis, Course, and Therapy.
Trainotti S; Johnson F; Hahn J; Hofauer B; Greve J; Wollenberg B; Hoffmann TK; Lochbaum R
J Allergy Clin Immunol Pract; 2023 Dec; 11(12):3772-3779. PubMed ID: 37716525
[TBL] [Abstract][Full Text] [Related]
12. Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic Patients.
Sobotkova M; Zachova R; Hakl R; Kuklinek P; Kralickova P; Krcmova I; Hanzlikova J; Vachova M; Bartunkova J
Int Arch Allergy Immunol; 2021; 182(7):642-649. PubMed ID: 33472202
[TBL] [Abstract][Full Text] [Related]
13. Lymphoproliferative disease and acquired C1 inhibitor deficiency.
Castelli R; Deliliers DL; Zingale LC; Pogliani EM; Cicardi M
Haematologica; 2007 May; 92(5):716-8. PubMed ID: 17488706
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies.
Cicardi M; Zingale LC; Pappalardo E; Folcioni A; Agostoni A
Medicine (Baltimore); 2003 Jul; 82(4):274-81. PubMed ID: 12861105
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Rituximab-Based Treatments in Angioedema With Acquired C1-Inhibitor Deficiency.
Kalmi G; Nguyen Y; Amarger S; Aubineau M; Bibes B; Blanchard-Delaunay C; Boccon-Gibod I; Bouillet L; Coppo P; Dalmas MC; Debord-Peguet S; Defendi F; Demoreuil C; Du-Thanh A; Gayet S; Hadjadj J; Jeandel PY; Launay D; Ly KH; Avoy CM; Niault M; Ollivier Y; Pelletier F; Porneuf M; Roos-Weil D; Fain O; Gobert D
J Allergy Clin Immunol Pract; 2024 Jan; 12(1):212-222. PubMed ID: 37844846
[TBL] [Abstract][Full Text] [Related]
16. A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency.
Pólai Z; Balla Z; Andrási N; Kőhalmi KV; Temesszentandrási G; Benedek S; Varga L; Farkas H
J Intern Med; 2021 Apr; 289(4):547-558. PubMed ID: 33215769
[TBL] [Abstract][Full Text] [Related]
17. C-1-inhibitor binding monoclonal immunoglobins in three patients with acquired angioneurotic edema.
Chevailler A; Arlaud G; Ponard D; Pernollet M; Carrère F; Renier G; Drouet M; Hurez D; Gardais J
J Allergy Clin Immunol; 1996 Apr; 97(4):998-1008. PubMed ID: 8655897
[TBL] [Abstract][Full Text] [Related]
18. The acquired C1-INH deficiencies with autoantibodies (AAE type II).
Alsenz J; Loos M
Behring Inst Mitt; 1989 Jul; (84):165-72. PubMed ID: 2679532
[TBL] [Abstract][Full Text] [Related]
19. C1-inhibitor deficiency and angioedema.
Carugati A; Pappalardo E; Zingale LC; Cicardi M
Mol Immunol; 2001 Aug; 38(2-3):161-73. PubMed ID: 11532278
[TBL] [Abstract][Full Text] [Related]
20. Acquired angioedema: Autoantibody associations and C1q utility as a diagnostic tool.
Breitbart SI; Bielory L
Allergy Asthma Proc; 2010; 31(5):428-34. PubMed ID: 20929611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]